Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Haapio

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|December 30, 2010
[New markers of acute kidney injury]Mikko Haapio, Johan Lassus
Duodecim; Laaketieteellinen Aikakauskirja|September 23, 2009
[Cardiorenal syndrome]Johan Lassus, Mikko Haapio
Contributions to Nephrology|May 3, 2008
BNP and a renal patient: emphasis on the unique characteristics of B-type natriuretic peptide in end-stage kidney diseaseMikko Haapio, Claudio Ronco
Contributions to Nephrology|June 5, 2009
Brain natriuretic peptide in peritoneal dialysis patientsMikko Haapio, Eero Honkanen, Claudio Ronco
Duodecim; Laaketieteellinen Aikakauskirja|November 22, 2012
[Extracorporeal blood purification for poisonings]Mikko Haapio, Anu Koivusalo, Heikki Mäkisalo
Nature Clinical Practice. Nephrology|April 10, 2008
Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensusClaudio Ronco, Andrew A House, Mikko Haapio
Intensive Care Medicine|February 6, 2008
Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrongClaudio Ronco, Andrew A House, Mikko Haapio
Frontiers in Immunology|April 21, 2020
Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case ReportA Inkeri Lokki, Mikko Haapio, Jenni Heikkinen-Eloranta
Kidney International Reports|December 23, 2017
One- and 2-Year Mortality Prediction for Patients Starting Chronic DialysisMikko Haapio, Jaakko Helve, Carola Grönhagen-Riska, et al.
Annals of Intensive Care|March 16, 2021
Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!Toni Jäntti, Veli-Pekka Harjola, Mikko Haapio, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Duodecim; Laaketieteellinen Aikakauskirja|December 30, 2010
[New markers of acute kidney injury]Mikko Haapio, Johan Lassus
Duodecim; Laaketieteellinen Aikakauskirja|September 23, 2009
[Cardiorenal syndrome]Johan Lassus, Mikko Haapio
Contributions to Nephrology|May 3, 2008
BNP and a renal patient: emphasis on the unique characteristics of B-type natriuretic peptide in end-stage kidney diseaseMikko Haapio, Claudio Ronco
Contributions to Nephrology|June 5, 2009
Brain natriuretic peptide in peritoneal dialysis patientsMikko Haapio, Eero Honkanen, Claudio Ronco
Duodecim; Laaketieteellinen Aikakauskirja|November 22, 2012
[Extracorporeal blood purification for poisonings]Mikko Haapio, Anu Koivusalo, Heikki Mäkisalo
Nature Clinical Practice. Nephrology|April 10, 2008
Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensusClaudio Ronco, Andrew A House, Mikko Haapio
Intensive Care Medicine|February 6, 2008
Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrongClaudio Ronco, Andrew A House, Mikko Haapio
Frontiers in Immunology|April 21, 2020
Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case ReportA Inkeri Lokki, Mikko Haapio, Jenni Heikkinen-Eloranta
Kidney International Reports|December 23, 2017
One- and 2-Year Mortality Prediction for Patients Starting Chronic DialysisMikko Haapio, Jaakko Helve, Carola Grönhagen-Riska, et al.
Annals of Intensive Care|March 16, 2021
Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!Toni Jäntti, Veli-Pekka Harjola, Mikko Haapio, et al.
Pageof 5